Alendronate Does Not Block the Anabolic Effect of PTH in Postmenopausal Osteoporotic Women [PDF]
Felicia Cosman +4 more
openalex +1 more source
Ageing brings about various biochemical, structural and mechanical alterations within tissues, profoundly impacting cellular behaviour and function. One of the hallmark changes observed with ageing is an increase in cellular microenvironment stiffness, a biomechanical property influenced by intrinsic factors within the cell and extrinsic factors from ...
Wang HaiYang +3 more
wiley +1 more source
Effects of resveratrol on postmenopausal women: a systematic review and meta-analysis. [PDF]
Wu W +7 more
europepmc +1 more source
This mediation analysis revealed that two BMI‐associated genetic variants, BDNF rs6265 and FTO rs1421085, may influence postmenopausal breast cancer risk through changes in BMI, and that BDNF rs6265 may also exert a direct effect through pathways independent of BMI.
Yuri Ando +11 more
wiley +1 more source
Exploring barriers to help-seeking for sexual issues in Iranian postmenopausal women: a qualitative analysis. [PDF]
Taherpour M +2 more
europepmc +1 more source
Genotype Distribution of Estrogen Receptor Polymorphisms in Men and Postmenopausal Women From Healthy and Coronary Populations and Its Relation to Serum Lipid Levels [PDF]
Yumiko Matsubara +8 more
openalex +1 more source
Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions
ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley +1 more source
Beyond Hormone Replacement: Multifaceted Effects of Phytoestrogens for Optimizing Kinesiological and Physiological Adaptations in Postmenopausal Women. [PDF]
Hu Y, Hu Y, Li T, Shi R.
europepmc +1 more source
Serum Estradiol Concentrations With Estradiol 0.06% Gel in Transgender and Gender‐Diverse Adults
ABSTRACT Objective Transgender and gender‐diverse individuals undergoing estradiol therapy for gender affirmation are typically treated with oral or transdermal estradiol, with transdermal estradiol recommended for those aged > 45 years. There are limited data evaluating estradiol gel in gender‐affirming hormone therapy regimens. We aimed to assess the
Raquel A. Maggacis +2 more
wiley +1 more source

